Harshad Devarbhavi, Susan Abraham, Patrick S. Kamath – 29 October 2007 – Nodular regenerative hyperplasia (NRH) of the liver usually occurs in patients with rheumatological and myelolymphoproliferative disorders; the occurrence post–liver transplantation (LT) has traditionally been ascribed to the use of azathioprine. We report the clinical, biochemical, and radiological features of 14 patients who developed NRH, unrelated to azathioprine in most cases, 3 months to 11 yr after orthotopic LT.

Olivier Boillot, Jérôme Dumortier – 29 October 2007

Alyssa Krasinskas – 29 October 2007

Shigeru Marubashi, Keizo Dono, Hiroaki Nagano, Tadafumi Asaoka, Naoki Hama, Shogo Kobayashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Morito Monden – 29 October 2007 – Little information is available on the characteristics and clinical significance of serum bilirubin level early after liver transplantation. The aim of this study was to clarify the risk factors for early graft loss and to assess the significance of postoperative hyperbilirubinemia as a predictor of graft outcome in living donor liver transplantation (LDLT).

Silvana Zanlungo, Juan Francisco Miquel, Flavio Nervi – 29 October 2007

Mark D. Gorrell – 29 October 2007

Giovanni L. Ricci, Maria Teresa Melgosa, Felip Burgos, José Luis Valera, Sandra Pizarro, Josep Roca, Roberto Rodriguez‐Roisin, Joan Albert Barberà – 29 October 2007 – The role of acute pulmonary vasodilator testing in portopulmonary hypertension (PoPH), a current contraindication for orthotopic liver transplantation (OLT), has not been thoroughly elucidated.

Manjushree Gautam, Kapil B. Chopra, David D. Douglas, Rebecca A. Stewart, Shimon Kusne – 29 October 2007 – Bacterial infections are a serious complication of end‐stage liver disease (ESLD) that occurs in 20% to 60% of patients. We retrospectively reviewed medical records of patients with ESLD who were identified by our microbiology laboratory as having Streptococcus salivarius bacteremia. Of 592 patients listed for transplantation between January 1998 and January 2006, 9 (1.5%) had 10 episodes of S salivarius bacteremia.

Josep M. Llovet – 29 October 2007

Kayvan Roayaie, Sandy Feng – 29 October 2007 – Currently, liver transplantation is the optimal cure for hepatocellular cancer (HCC) limited to the liver.